Biological
Ultrasound-guided platelet-rich-plasma (PRP) injection
Ultrasound-guided platelet-rich-plasma (PRP) injection is a biological therapy with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
BIOLOGICAL
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
50%(1 trials)
Phase Distribution
Ph not_applicable
1
33%
Ph phase_2
1
33%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution2 total trials
Phase 2Efficacy & side effects
1(50.0%)
N/ANon-phased studies
1(50.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(2)
Other(1)
Detailed Status
Completed2
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 21 (50.0%)
N/A1 (50.0%)
Trials by Status
unknown133%
completed267%
Recent Activity
0 active trials
Showing 3 of 3
completednot_applicable
Treatment of Acute and Chronic Ligament and Tendon Injuries With Platelet Rich Plasma
NCT01406821
completed
Performance-Enhancing Effects of Platelet-Rich Plasma (PRP) Injections
NCT01200875
unknownphase_2
Impact of Autologous Pure Platelet-rich Plasma in the Treatment of Tendon Disease
NCT03300531
Clinical Trials (3)
Showing 3 of 3 trials
NCT01406821Not Applicable
Treatment of Acute and Chronic Ligament and Tendon Injuries With Platelet Rich Plasma
NCT01200875
Performance-Enhancing Effects of Platelet-Rich Plasma (PRP) Injections
NCT03300531Phase 2
Impact of Autologous Pure Platelet-rich Plasma in the Treatment of Tendon Disease
All 3 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 3